Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2016

01.01.2016 | Clinical Study

Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey

verfasst von: Tobias Walbert, Michael Glantz, Lonni Schultz, Vinay K. Puduvalli

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Specialized palliative care (PC) services have emerged to address symptoms and provide end-of-life management for patients with brain tumors. The utilization patterns of PC in neuro-oncology are unknown. A 22-question survey was distributed to participants of the society for neuro-oncology annual meeting 2012 (n = 4487). Nonparametric methods including Wilcoxon two-sample and Kruskal–Wallis tests were used to assess differences in responses. 239 (5.3 %) evaluable responses were received; 79 % of respondents were physicians, and 17 % were nurses or midlevel providers. Forty-seven percent were medical or neuro-oncologists, 31 % neurosurgeons and 11 % radiation oncologists. Forty percent had no formal training in PC, 57 % had some formal training and 3 % completed a PC fellowship. Seventy-nine percent practiced in an academic setting. Of the respondents, 57 % referred patients to PC when symptoms required treatment and 18 % at end of life. Only 51 % of all providers felt comfortable dealing with end-of-life issues and symptoms, while 33 % did not. Fifty-one percent preferred a service named “Supportive Care” rather than “Palliative Care” (MDs > midlevel providers, p < 0.001), and 32 % felt that patient expectations for ongoing therapy hindered their ability to make PC referrals. Female gender, formal training in neuro-oncology and PC, and medical versus surgical neuro-oncology training were significantly associated with hospice referral, comfort in dealing with end-of-life issues, and ease of access to PC services. Provider level, specialty, gender, training in PC and neuro-oncology have significant impact on the utilization of PC and hospice in neuro-oncology.
Literatur
1.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef
3.
Zurück zum Zitat Prados MD, Seiferheld W, Sandler HM et al (2004) Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58:1147–1152PubMedCrossRef Prados MD, Seiferheld W, Sandler HM et al (2004) Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58:1147–1152PubMedCrossRef
4.
Zurück zum Zitat van den Bent MJ, Carpentier AF, Brandes AA et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715–2722PubMedCrossRef van den Bent MJ, Carpentier AF, Brandes AA et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715–2722PubMedCrossRef
5.
Zurück zum Zitat Minniti G, Scaringi C, Baldoni A et al (2013) Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. Int J Radiat Oncol Biol Phys 86:285–291PubMedCrossRef Minniti G, Scaringi C, Baldoni A et al (2013) Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. Int J Radiat Oncol Biol Phys 86:285–291PubMedCrossRef
6.
Zurück zum Zitat Armstrong TS, Wefel JS, Wang M et al (2013) Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol 31:4076–4084PubMedPubMedCentralCrossRef Armstrong TS, Wefel JS, Wang M et al (2013) Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol 31:4076–4084PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Walbert T, Khan M (2014) End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol 117:217–224PubMedCrossRef Walbert T, Khan M (2014) End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol 117:217–224PubMedCrossRef
9.
Zurück zum Zitat Walbert T (2014) Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neuro-Oncol Pract 1:3–7CrossRef Walbert T (2014) Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neuro-Oncol Pract 1:3–7CrossRef
10.
Zurück zum Zitat Dionne-Odom JN, Azuero A, Lyons KD et al (2015) Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol 33:1446–1452PubMedCrossRef Dionne-Odom JN, Azuero A, Lyons KD et al (2015) Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol 33:1446–1452PubMedCrossRef
11.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef
12.
Zurück zum Zitat Bakitas MA, Tosteson TD, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33:1438–1445PubMedCrossRef Bakitas MA, Tosteson TD, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33:1438–1445PubMedCrossRef
13.
Zurück zum Zitat Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887PubMedCrossRef Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887PubMedCrossRef
14.
Zurück zum Zitat Walbert T, Puduvalli VK, Taphoorn MJ et al (2015) International patterns of palliative care in neuro-oncology: a survey of physician members of the Asian Society for Neuro-Oncology, the European Association of Neuro-Oncology, and the Society for Neuro-Oncology. Neuro-Oncol Pract 2:62–69CrossRef Walbert T, Puduvalli VK, Taphoorn MJ et al (2015) International patterns of palliative care in neuro-oncology: a survey of physician members of the Asian Society for Neuro-Oncology, the European Association of Neuro-Oncology, and the Society for Neuro-Oncology. Neuro-Oncol Pract 2:62–69CrossRef
15.
Zurück zum Zitat Dalal S, Palla S, Hui D et al (2011) Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist 16:105–111PubMedPubMedCentralCrossRef Dalal S, Palla S, Hui D et al (2011) Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist 16:105–111PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Fadul N, Elsayem A, Palmer JL et al (2009) Supportive versus palliative care: what’s in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer 115:2013–2021PubMedCrossRef Fadul N, Elsayem A, Palmer JL et al (2009) Supportive versus palliative care: what’s in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer 115:2013–2021PubMedCrossRef
18.
19.
Zurück zum Zitat Stockham AL, Ahluwalia M, Reddy CA et al (2013) Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS. J Neurooncol 115:469–475PubMedCrossRef Stockham AL, Ahluwalia M, Reddy CA et al (2013) Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS. J Neurooncol 115:469–475PubMedCrossRef
20.
Zurück zum Zitat Kirby E, Broom A, Good P (2014) The role and significance of nurses in managing transitions to palliative care: a qualitative study. BMJ Open 4:e006026PubMedPubMedCentralCrossRef Kirby E, Broom A, Good P (2014) The role and significance of nurses in managing transitions to palliative care: a qualitative study. BMJ Open 4:e006026PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Skilbeck J, Payne S (2003) Emotional support and the role of clinical nurse specialists in palliative care. J Adv Nurs 43:521–530PubMedCrossRef Skilbeck J, Payne S (2003) Emotional support and the role of clinical nurse specialists in palliative care. J Adv Nurs 43:521–530PubMedCrossRef
22.
Zurück zum Zitat Wentlandt K, Krzyzanowska MK, Swami N et al (2012) Referral practices of oncologists to specialized palliative care. J Clin Oncol 30:4380–4386PubMedCrossRef Wentlandt K, Krzyzanowska MK, Swami N et al (2012) Referral practices of oncologists to specialized palliative care. J Clin Oncol 30:4380–4386PubMedCrossRef
23.
Zurück zum Zitat Ahmed N, Bestall JC, Ahmedzai SH et al (2004) Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med 18:525–542PubMedCrossRef Ahmed N, Bestall JC, Ahmedzai SH et al (2004) Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med 18:525–542PubMedCrossRef
24.
Zurück zum Zitat Charalambous H, Pallis A, Hasan B et al (2014) Attitudes and referral patterns of lung cancer specialists in Europe to Specialized Palliative Care (SPC) and the practice of Early Palliative Care (EPC). BMC Palliat Care 13:59PubMedPubMedCentralCrossRef Charalambous H, Pallis A, Hasan B et al (2014) Attitudes and referral patterns of lung cancer specialists in Europe to Specialized Palliative Care (SPC) and the practice of Early Palliative Care (EPC). BMC Palliat Care 13:59PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Johnson CE, Girgis A, Paul CL et al (2008) Cancer specialists’ palliative care referral practices and perceptions: results of a national survey. Palliat Med 22:51–57PubMedCrossRef Johnson CE, Girgis A, Paul CL et al (2008) Cancer specialists’ palliative care referral practices and perceptions: results of a national survey. Palliat Med 22:51–57PubMedCrossRef
Metadaten
Titel
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
verfasst von
Tobias Walbert
Michael Glantz
Lonni Schultz
Vinay K. Puduvalli
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1973-0

Weitere Artikel der Ausgabe 2/2016

Journal of Neuro-Oncology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.